Cellid Ltd.
Cellid Co., Ltd. develops immunotherapeutic vaccines for oncology and infectious diseases. Its pipeline—BVAC‑C, BVAC‑B, BVAC‑P, BVAC‑M, and personalized BVAC‑Neo—targets HPV‑related, HER‑2, PSA, and melanoma cancers, positioning the company in emerging precision‑medicine markets.
Headquarters: South Korea (KOR)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- HQ: Seoul
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.